Skip to main content

Month: August 2020

Contemplating issuance of senior non-preferred bond

SpareBank 1 SMN has mandated DNB Markets, SEB and SpareBank 1 Markets for a potential issuance of a senior non-preferred bond. The transaction is subject to market conditions.Contact SpareBank 1 SMN:Deputy Head of treasury Per Egil Aamo, telephone +47 73 58 64 66This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Continue reading

Mulig utstedelse av senior etterstilt obligasjonslån

SpareBank 1 SMN har mandatert DNB Markets, SEB og SpareBank 1 Markets for mulig utstedelse av et nytt senior etterstilt obligasjonslån. Transaksjonen er ventet å bli offentliggjort i nærmeste fremtid, avhengig av markedsforhold.Kontaktperson i SpareBank 1 SMNAss.finansjef Per Egil Aamo, telefon: 73 58 64 66Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Continue reading

Enterprises in Germany Embrace Cyber Security Providers to Comply with Regulations

FRANKFURT, Germany, Aug. 24, 2020 (GLOBE NEWSWIRE) — Facing data protection regulations and new cyber threats during the COVID-19 pandemic, enterprises in Germany are looking to service providers to improve their cyber security, according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.The 2020 ISG Provider Lens™ Cyber Security – Solutions & Services Report for Germany finds interest in cyber security providers is growing as more and more business processes are being digitized and use of the industrial Internet of Things continues to increase.In addition, the Data Protection Regulation is driving German companies to implement stronger cyber security measures, the report says. The COVID-19 pandemic is also creating new challenges for German...

Continue reading

Deutsche Unternehmen wenden sich aus regulatorischen Gründen Cyber-Security-Anbietern zu

FRANKFURT, Deutschland, Aug. 24, 2020 (GLOBE NEWSWIRE) — Im Zuge der COVID-19-Pandemie sehen sich Unternehmen in Deutschland derzeit mit strengeren Datenschutzbestimmungen und neuen Cyber-Gefahren konfrontiert. Vor diesem Hintergrund wenden sie sich verstärkt an Service-Anbieter, um ihre Cyber-Sicherheit zu verbessern. Dies meldet eine heute veröffentlichte Studie der Information Services Group (ISG) (Nasdaq: III), ein führendes globales Marktforschungs- und Beratungsunternehmen im Technologiesegment.Dem „ISG Provider Lens™ Cyber Security – Solutions & Services Report Germany 2020“ zufolge steigt die Nachfrage nach Cyber-Security-Diensten derzeit, da mehr und mehr Geschäftsprozesse digitalisiert werden und die Nutzung des Industrial Internet of Things weiter ansteigt.Darüber hinaus führt die Datenschutzgrundverordnung (DSGVO)...

Continue reading

CLS and Advanced Medical Systems Form Joint Venture Cooperation, Introducing the Innovative TRANBERG® Thermal Therapy System and imILT® in the Asia-Pacific Region

LUND, Sweden, Aug. 24, 2020 (GLOBE NEWSWIRE) — Clinical Laserthermia Systems AB (publ) (CLS), developer of innovative image-guided laser ablation technology for minimally invasive soft tissue and cancer tumor treatment, and Advanced Medical Systems Pte Ltd (AMS), a high-end provider of medical devices, systems, and services for the Asia-Pacific region. The companies have entered into a collaborative agreement where the parties through a joint venture company, Clinical Asia Pacific Pte. Ltd., will launch the TRANBERG® Thermal Therapy System and imILT®treatment protocol in the rapidly growing Asia-Pacific market. The first step is to initiate the regulatory processes and market preparations needed in order to successfully launch CLS’ products and therapy in the region.“Clinical Asia Pacific is ready to start its operation in Singapore...

Continue reading

Notification on the disposal of the voting rights

AB Linas Agro Group received the notification from Andrius Pranckevičius  on disposal of voting rights (see attachment). The reason for crossing the threshold – changes in legal regulation. The declared threshold that was crossed – 5%.For more information please contact Finance Director Mažvydas Šileika, mob.  +370 619 19 403, e-mail m.sileika@linasagro.lt.AttachmentNotification on the disposal of the voting rights_Andrius_Pranckevicius

Continue reading

SERSTECH AB: Serstech receives 5.3 MSEK order from Asian partner DKSH

Serstech today received a 5.3 MSEK order from its Asian partner DKSH. DKSH will deliver the products to a national narcotics police organization in South-East Asia. The order consists of the Serstech 100 Indicator and ChemDash software and will be delivered and invoiced in Q3 2020.The order is based on a tender that was cancelled in Q2 due to the uncertainties created by the Corona pandemic. The tender was reopened again recently, since the police needed to get access to modern tools to battle the problems with narcotics – problems that have escalated over the last few months.“DKSH has been a Serstech sales partner since early 2019 and has more than 100 years of experience in the Asian markets. Getting such an order so quickly is a testament to their skills and deep understanding of their market”, says Serstech CEO Stefan Sandor.“Serstech...

Continue reading

Chi-Med Highlights Clinical Data to be Presented at the Upcoming ESMO Virtual Congress 2020

HONG KONG and FLORHAM PARK, N.J., Aug. 24, 2020 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) today announces that new and updated analyses on the studies of surufatinib and fruquintinib will be presented at the upcoming European Society for Medical Oncology (ESMO) Virtual Congress 2020, taking place on September 17-21, 2020.Further details of the presentations are as follows:SURUFATINIB

Continue reading

Saniona Announces Poster Presentation at the European Congress of Endocrinology Virtual Annual Meeting

PRESS RELEASE24 August 2020Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that a poster highlighting results from a phase 2 clinical trial of Tesomet for hypothalamic obesity will be presented at the 22nd European Congress of Endocrinology virtual annual meeting being held 5-9 September 2020. Professor Ulla Feldt-Rasmussen, M.D. DMSc (Department of Medical Endocrinology and Metabolism, Rigshospitalet Copenhagen University Hospital) will present the poster titled “A Randomized-Controlled Trial of Tesomet Resulted in Significant Weight Loss in Hypopituitary Patients with Hypothalamic Obesity”.For more information, please contactRudolf Baumgartner, CMO & Head of Clinical Development, Saniona, Email: rudolf.baumgartner@saniona.comThe information was submitted for publication,...

Continue reading

Saniona tillkännager presentationen av en poster vid den europeiska endokrinologikongressens virtuella årsmöte

PRESSMEDDELANDE24 augusti 2020Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att en poster som illustrerar resultaten från en Fas 2-studie med Tesomet mot hypotalamisk fetma kommer att presenteras vid e-ECE-2020, den europeiska endokrinologikongressen, som i år hålls virtuellt 5-9 september. Professor Ulla Feldt-Rasmussen, M.D. DMSc (Avdelningen för medicinsk endokrinologi och metabolism, Rigshospitalet, Köpenhamns Universitetssjukhus) kommer att presentera postern, som fått rubriken “A Randomized-Controlled Trial of Tesomet Resulted in Significant Weight Loss in Hypopituitary Patients with Hypothalamic Obesity”.För mer information, var vänlig kontaktaRudolf Baumgartner, CMO & Head of Clinical Development, Saniona, E-post: rudolf.baumgartner@saniona.comInformationen...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.